Insider Trading March 25, 2026

AMETEK Director Sells $114,893 in Stock as Company Posts Strong Q4; Valuation Flagged by Analysis

Thomas A. Amato reduces a portion of his direct holdings while AMETEK reports record orders and a sizable backlog

By Hana Yamamoto AME
AMETEK Director Sells $114,893 in Stock as Company Posts Strong Q4; Valuation Flagged by Analysis
AME

AMETEK director Thomas A. Amato sold 530 shares of the company's common stock on March 24, 2026, realizing $114,893 at $216.78 per share. The transaction leaves Amato with 4,480 directly held shares and 7,000 indirectly held shares via a trust. The trade occurred while AMETEK shares traded near $215.47 and were up more than 21% over the last year, trading at a price-to-earnings ratio of 33.9. InvestingPro analysis characterizes the stock as currently overvalued versus its Fair Value. Separately, AMETEK reported a robust fourth quarter with 13% year-over-year sales growth and record orders and backlog, prompting several analysts to raise price targets.

Key Points

  • Director Thomas A. Amato sold 530 shares at $216.78 on March 24, 2026, netting $114,893 and retaining 4,480 direct shares.
  • Amato also disposed of 500 shares and purchased 500 shares on the same day, and indirectly holds 7,000 shares through a trust where he is trustee.
  • AMETEK reported 13% year-over-year Q4 sales growth (5% organic, 7% acquisitions, 1% FX), record orders of $2 billion, a backlog of $3.58 billion, and a 1.02x book-to-bill ratio; several analysts raised price targets following the results.

Insider transaction details

On March 24, 2026, Thomas A. Amato, a director at AMETEK INC. (NYSE: AME), sold 530 shares of AMETEK common stock at a price of $216.78 per share, producing proceeds of $114,893. After completing that sale, Amato directly holds 4,480 shares of the company.

On the same date, Amato additionally executed transactions that included the disposition of 500 shares and the acquisition of 500 shares of AMETEK common stock.


Ownership structure and indirect holdings

Beyond his direct holdings, Amato is listed as trustee of a trust that holds 7,000 shares of AMETEK. Those trust-held shares are counted as indirect ownership for Amato.


Market context and valuation

The director's sale occurred as AMETEK shares were trading near $215.47. The stock has gained in excess of 21% over the past 12 months and is currently trading at a price-to-earnings ratio of 33.9. According to InvestingPro analysis cited with the company data, AMETEK's current market price appears overvalued when compared with its Fair Value.


Company financials and operational highlights

AMETEK reported a strong fourth quarter, with total sales up 13% year-over-year. The company attributed that increase to three components: 5% organic growth, a 7% contribution from acquisitions, and a 1% benefit from foreign exchange. In the period, AMETEK recorded a new high in orders at $2.0 billion and reported a record backlog of $3.58 billion, producing a book-to-bill ratio of 1.02x.


Analyst reactions

Analysts responded to the quarter by raising price targets for the stock. DA Davidson lifted its target to $265 while maintaining a Buy rating and cited solid growth and a strong backlog. Truist Securities also moved its target to $265, pointing to a strong outlook. KeyBanc Capital Markets adjusted its target to $260, highlighting the company’s robust order numbers. RBC Capital set a new target of $257, noting a modest operating beat along with guidance for 2026 that it characterized as in line with expectations.


What the filings show

The filings reflect a combination of direct and indirect ownership changes by a company director on a single trading date, occurring against a backdrop of positive company metrics and analyst target increases. The valuation assessment from InvestingPro, which indicates the stock may be overvalued relative to its Fair Value, is presented alongside the operational and financial improvements reported by the company.


Bottom line

The transactions reported by Director Thomas A. Amato on March 24, 2026, adjust his direct and indirect holdings in AMETEK while the company posts record orders and backlog and receives upward revisions to price targets from several analysts. At the same time, third-party analysis flags the stock as overvalued versus its Fair Value, and the shares trade at a relatively elevated P/E of 33.9.

Risks

  • Valuation risk - InvestingPro analysis indicates AMETEK appears overvalued relative to its Fair Value, and the shares trade at a P/E of 33.9 - this impacts equity investors considering valuation-sensitive sectors.
  • Insider activity ambiguity - The mix of sales and same-day buy/sell transactions by a director may leave questions about the timing and intent of trades, which could affect investor perception in the industrials and manufacturing equipment sectors.
  • Guidance sensitivity - RBC Capital noted an in-line 2026 guidance despite a modest operating beat, implying that future company performance and guidance execution remain potential sources of uncertainty for market participants.

More from Insider Trading

Ridgepost Capital Director Disposes $515,900 of Stock; Company Near 52-Week Low Mar 25, 2026 Tempest Therapeutics CEO Makes $500,001 Equity Purchase as Company Advances CAR-T Strategy Mar 25, 2026 Flowco Holdings Insider Move: Director Sells $165M in Class A Shares, Also Records Conversion-Based Acquisition Mar 25, 2026 FRP Holdings Director Acquires Nearly $10 Million in Stock Mar 25, 2026 Hyperfine COO Sells Shares to Cover RSU Taxes After Strong 2025 Results Mar 25, 2026